Dr. Reddy's Laboratories Limited (RDY)
$12.22+0.33%Close
BUYRECOVERY · day 15
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $10.2B
- Avg volume
- 2.7M
- Beta
- 0.25
- Div yield
- 0.67%
- P/E (TTM)
- 29.96
- Short % float
- 2.51%
- Days to cover
- 6.9
- SI change
- -0.4%
- 1W
- +0.91%
- 1M
- +3.65%
- 3M
- -10.15%
- YTD
- -11.83%
- vs SPY 1W
- +2.10%
- vs SPY 1M
- +0.33%
- vs SPY 3M
- -12.54%
- vs SPY YTD
- -23.59%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- FTHBUYRECOVERYQ -5$34.71+8.47%
- CNMDBUYCONMED CorporationRECOVERYQ 13$51.49+0.82%
- CONBUYConcentra Group Holdings Parent, Inc.BULLQ 41$34.99-0.03%
- MMSIBUYMerit Medical Systems, Inc.BULLQ 13$90.28-0.55%
- ATNMBUYActinium Pharmaceuticals, Inc.RECOVERYQ -1$1.05-4.55%
- HCABUYHCA Healthcare, Inc.RECOVERYQ 24$430.39+0.28%
- ALCBUYAlcon Inc.RECOVERYQ 11$73.70+0.10%
- IDXXSELLIDEXX Laboratories, Inc.RECOVERYQ 30$559.51+0.46%
- HSTMBUYHealthStream, Inc.BULLQ 12$28.78-0.31%
- SHCBUYSotera Health CompanyBULLQ 10$19.17-2.04%
- TECHBUYBio-Techne CorporationBULLQ 18$72.39+0.10%
- OSCRBUYOscar Health, Inc.RECOVERYQ 11$31.81-0.72%
Industry peers
FMP comparable companies · ranked by market cap
- RVMDBUYRevolution Medicines, Inc.$44.5BBULLQ 31$209.46+1.01%
- VTRSSELLViatris Inc.$19.0BBEARQ 4$16.32+1.35%
- SOLVBUYSolventum Corporation$15.5BBULLQ 16$89.57+1.88%
- NBIXSELLNeurocrine Biosciences, Inc.$15.3BBEARQ 17$152.57+0.31%
- RVTYBUYRevvity, Inc.$13.9BBULLQ 10$124.75-1.40%
- EXELSELLExelixis, Inc.$13.6BBEARQ 10$54.08+0.87%
- BMRNBUYBioMarin Pharmaceutical Inc.$12.9BBULLQ 12$66.70-2.44%
- ELANSELLElanco Animal Health Incorporated$12.0BRECOVERYQ 3$23.97+1.88%
- EHCBUYEncompass Health Corporation$11.9BBULLQ 15$120.31+0.51%
- ENSGBUYThe Ensign Group, Inc.$10.5BRECOVERYQ 28$179.48-0.06%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 32
- VALUE
- 23
- GROWTH
- 68
- GARP
- 14
- TYPE
- Value / Recovery (blended)
Composite of Value · Growth · GARP
ROIC5.3%
REV YoY-
ROE3.2%
EPS YoY-
ROA5.8%
GROSS50
OP11
NET10
[VALUATION]
P/E TTM29.96
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.61
P/B2.58
P/FCF-
EV/EBITDA16.72
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E18.77
ALTMAN Z-
CURR RATIO1.90
ND/EBITDA-
BETA0.25
